Asia Pacific Aesthetic Medicine Market Size & Outlook
The aesthetic medicine market in Asia Pacific is expected to reach a projected revenue of US$ 60,567.5 million by 2033. A compound annual growth rate of 14.2% is expected of Asia Pacific aesthetic medicine market from 2025 to 2033.
The Asia Pacific aesthetic medicine market generated a revenue of USD 18,413.3 million in 2024.
The market is expected to grow at a CAGR of 14.2% from 2025 to 2033.
In terms of segment, invasive procedures was the largest revenue generating type in 2024.
Non-invasive procedures is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, India is expected to register the highest CAGR from 2025 to 2033.
Asia Pacific data book summary
Market revenue in 2024
USD 18,413.3 million
Market revenue in 2033
USD 60,567.5 million
Growth rate
14.2% (CAGR from 2025 to 2033)
Largest segment
Invasive procedures
Fastest growing segment
Non-invasive procedures
Historical data covered
2021 - 2023
Base year for estimation
2024
Forecast period covered
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Invasive procedures, Non-invasive procedures
Key market players worldwide
AbbVie Inc, Cynosure, Evolus Inc, Lumenis, Bausch Health Companies Inc, Fosun International Ltd, Revance Therapeutics Inc, Candela Medical
Other key industry trends
In terms of revenue, Asia Pacific region accounted for 20.5% of the global aesthetic medicine market in 2024.
Globally, Europe is projected to lead the regional market in terms of revenue in 2033.
Europe is the fastest growing regional market and is projected to reach USD 90,166.1 million by 2033.
Asia Pacific aesthetic medicine market is expected to grow at a rapid pace during the forecast period. A large number of surgical procedures are performed i n South Korea, Japan, & China each year, availability of skilled & trained professionals, and low procedural costs are factors driving market growth in the APAC region.
Furthermore, an increase in the number of working professionals and high disposable income are factors leading to increased demand for aesthetic procedures in the region.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Medicine Market Outlook will help companies and investors design strategic landscapes.
Invasive Procedures was the largest segment with a revenue share of 59.45% in 2024.
Horizon Databook has segmented the Asia Pacific aesthetic medicine market based on invasive procedures, non-invasive procedures covering the revenue growth of each sub-segment from 2021 to 2033.
Asia Pacific aesthetic medicine market is expected to grow at a rapid pace during the forecast period. A large number of surgical procedures are performed i n South Korea, Japan, & China each year, availability of skilled & trained professionals, and low procedural costs are factors driving market growth in the APAC region.
Furthermore, an increase in the number of working professionals and high disposable income are factors leading to increased demand for aesthetic procedures in the region.
Asia Pacific Aesthetic Medicine Market Type Outlook (Revenue, USD Million , 2021-2033)
Invasive procedures
Non-invasive procedures
Asia Pacific Aesthetic Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Clinics & Aesthetic Centers
Medspas
Reasons to subscribe to Aesthetic Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Medicine Market Outlook databook
Our clientele includes a mix of Aesthetic Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Aesthetic Medicine Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Aesthetic Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Aesthetic Medicine Market, 2021-2033 (US$M)